238 related articles for article (PubMed ID: 4817094)
1. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
Nilsson IM; Hedner U; Holmberg L
Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
[No Abstract] [Full Text] [Related]
2. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
Nilsson IM; Berntorp E
Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
[No Abstract] [Full Text] [Related]
3. Management of haemophilia A with antibodies--the effect of combined treatment with factor VIII, hydrocortisone and cyclophosphamide.
Hedner U; Tengborn L
Thromb Haemost; 1985 Dec; 54(4):776-9. PubMed ID: 3937274
[TBL] [Abstract][Full Text] [Related]
4. Failure of combined factor VIII and cyclophosphamide to suppress antibody to factor VIII in hemophilia.
Hruby MA; Schulman I
Blood; 1973 Dec; 42(6):919-23. PubMed ID: 4759918
[No Abstract] [Full Text] [Related]
5. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
Nilsson IM; Berntorp E; Zettervall O
N Engl J Med; 1988 Apr; 318(15):947-50. PubMed ID: 3127711
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression of patients with acquired factor VIII inhibitors.
Green D
Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780
[No Abstract] [Full Text] [Related]
7. The use of porcine factor VIII in Japan.
Yoshioka A; Shima M; Morichika S; Terada S; Fukui H
Semin Hematol; 1994 Apr; 31(2 Suppl 4):26-8. PubMed ID: 7939769
[No Abstract] [Full Text] [Related]
8. The suppression of factor VIII antibodies in haemophilia.
Dormandy KM; Sultan Y
Pathol Biol (Paris); 1975 Dec; 23 suppl():17-23. PubMed ID: 772555
[TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
[TBL] [Abstract][Full Text] [Related]
10. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
Kessler CM; Ludlam CA
Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
[No Abstract] [Full Text] [Related]
11. Regimens of factor VIII administration--continuous infusion vs. bolus.
Berntorp E
Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hemophilia complicated by inhibitors.
Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
[No Abstract] [Full Text] [Related]
13. [Successful cyclosporin therapy of acquired hemophilia caused by factor VIII (VIII:C) inhibiting antibody].
Pfliegler G; Boda Z; Hársfalvi J; Flóra-Nagy M; Sári B; Pecze K; Rák K
Orv Hetil; 1991 Jul; 132(27):1485-8. PubMed ID: 1956679
[TBL] [Abstract][Full Text] [Related]
14. Acquired haemophilia.
Mehta JB; Mehta S
J Assoc Physicians India; 1990 Dec; 38(12):895-6. PubMed ID: 2128938
[TBL] [Abstract][Full Text] [Related]
15. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
Hertzberg MS; Favaloro E; Koutts J
Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
[No Abstract] [Full Text] [Related]
16. The importance of corticoids added to continued treatment with Factor VIII concentrates in the suppression of inhibitors in haemophilia A.
Aznar JA; Jorquera JI; Peiró A; Garcia I
Thromb Haemost; 1984 Apr; 51(2):217-21. PubMed ID: 6429884
[TBL] [Abstract][Full Text] [Related]
17. [Elimination of inhibitors in children with hemophilia A].
Weissbach G; Domula M; Lenk H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):817-25. PubMed ID: 6083958
[TBL] [Abstract][Full Text] [Related]
18. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
Hay CR; Lozier JN; Lee CA; Lafan M; Tradati H; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A
Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768
[No Abstract] [Full Text] [Related]
19. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
Lange D; Lazerson J
Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
[No Abstract] [Full Text] [Related]
20. Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors.
Ruggeri ZM; Mannucci PM; Allain JP; Frommel D
Ann N Y Acad Sci; 1975 Jan; 240():412-8. PubMed ID: 1053886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
